Eloxx Pharmaceuticals, Inc. Common Stock

ELOXNASDAQ • USD
13.17 USD
↗ 0.37 (2.89%)AT CLOSE (03:59 PM EDT)
13.17
↘ 0.01 (0.04%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
13.17
↘ 0.01 (0.04%)
🔴Market: CLOSED

Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) is currently trading at $13.22. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (62.7%) and a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Oct 26, 2026.

Open?$13.16
High?$13.35
Low?$12.89
Prev. Close?$12.80
Volume?26.7K
Avg. Volume?24.8K
VWAP?$13.04
Rel. Volume?1.07x
Bid / Ask
Bid?$12.12 × 100
Ask?$14.00 × 200
Spread?$1.88
Midpoint?$13.06
Valuation & Ratios
Market Cap?45.3M
Shares Out?4.0M
Float?3.2M
Float %?78.4%
P/E Ratio?N/A
P/B Ratio?-2.00
EPS?-$4.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Employees
7
Market Cap
44.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1998-12-11
Address
P.O. BOX 274
ARLINGTON, MA 02476
Phone: 781-577-5300
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
74
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.96Distress
Confidence?39%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.31%Low
Short Interest?41.3K
Days to Cover?1.8
Free Float3.2M
Avg Daily Volume23.2K
Settlement Date2026-10-15
Financial Health
Current Ratio?0.07Weak
Quick Ratio?0.07Weak
Cash Ratio?0.05Low
Debt/Equity?-0.17Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-2.00CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.8CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
93
62.7%STRONG▾
ROA?
S&P
3
-827.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$48.0M
Fundamentals ratios updated end of day